Advertisement

Topics

Latest "Global Initiative Alzheimer Disease Optum Labs" News Stories

09:17 EST 13th December 2018 | BioPortfolio

Here are the most relevant search results for "Global Initiative Alzheimer Disease Optum Labs" found in our extensive news archives from over 250 global news sources.

More Information about Global Initiative Alzheimer Disease Optum Labs on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Global Initiative Alzheimer Disease Optum Labs for you to read. Along with our medical data and news we also list Global Initiative Alzheimer Disease Optum Labs Clinical Trials, which are updated daily. BioPortfolio also has a large database of Global Initiative Alzheimer Disease Optum Labs Companies for you to search.

Showing "Global Initiative Alzheimer Disease Optum Labs" News Articles 1–25 of 31,000+

Extremely Relevant

Global CEO Initiative: Andrea Pfeifer & George Vradenburg. Working together on the global fight to stop Alzheimer’s disease

In this episode of PharmaTelevision News Review, filmed at Bio Conference 2013, in Chicago, USA, Fintan Walton talks to Andrea Pfeifer & George Vradenburg from the Global CEO Initiative


Businessman issues global, multimillion dollar (USD) challenge for Alzheimer's solutions

(University of Texas at San Antonio) To expand the understanding and explanation of Alzheimer's disease, U.S. businessman James Truchard has given a $5 million USD gift to The University of Texas at San Antonio (UTSA) College of Sciences to establish the Oskar Fischer Project. The initiative, the largest of its kind, will engage the world's brightest minds in a comprehensive literature review with...

Global Alzheimer’s Disease Epidemiology, Patient Flow, Prevalence and Diagnosed & Treated Patients Analysis – 2018 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Alzheimer’s Disease Epidemiology and Patient Flow Analysis – 2018” report has been added to ResearchAndMarkets.com’s offering. This research provides insights into Alzheimer’s Disease epidemiology, Alzheimer’s Disease diagnosed patients, and Alzheimer’s Disease treatment rate for US, Japan, and … C...


Alzheimer Disease | Medscape

Review in-depth clinical information, latest medical news, and guidelines on Alzheimer Disease. Recognize the causes of Alzheimer Disease and signs of Alzheimer Disease, including dementia.

Global Alzheimer's Disease Market and Competitive Landscape 2014-2023: Pipeline, Epidemiology, ...

DUBLIN, Oct 30, 2018 /PRNewswire/ -- The "Global Alzheimer's Disease Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. Global Alzheimer's Read more...

Relevant

Update on Phase III clinical trials of lanabecestat for Alzheimer's disease

AstraZeneca and Eli Lilly and Company (Lilly) are discontinuing the global Phase III clinical trials of lanabecestat, an oral beta secretase cleaving enzyme (BACE) inhibitor, for the treatment of Alzheimer's disease. The decision is based on recommendations by an independent data monitoring committee (IDMC), which concluded that both the AMARANTH trial, in early Alzheimer's disease, and the DAYBRE...

Study partners: essential collaborators in discovering treatments for Alzheimer’s disease

Global leaders have set an ambitious goal of developing interventions to effectively treat or prevent Alzheimer’s disease by 2025.

Classifying Alzheimer's patients in 6 subgroups

Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments. "Alzheimer's, like breast cancer, is not one disease," said lead author Shubhabrata Mukherjee, research assistant professor i...

Sex matters: Addressing the Alzheimer's disease research gap

(Society for Women's Health Research) To prevent and treat Alzheimer's disease, scientists need to better understand how the disease differs between women and men, according to a paper published June 12 in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

Physical activity may have beneficial effects for people with rare Alzheimer's disease

For individuals carrying a genetic mutation that causes Alzheimer's disease, engaging in at least 2.5 hours of physical activity per week may have beneficial effects on markers of Alzheimer's disease brain changes and may delay cognitive decline, according to a new study available online by Alzheimer's & Dementia: The Journal of the Alzheimer's Association as an article in press, corrected proof.

We Need New Biomarkers for Alzheimer's Disease

They're essential to coming up with better treatments, and a new initiative could provide them -- Read more on ScientificAmerican.com

CDC: 14 Million Americans Will Have Alzheimer’s by 2060

Incidence of Alzheimer’s disease is projected to double in the next 40 years unless a cure or preventive measures are found. The U.S. Centers for Disease Control and Prevention published a new report in the journal Alzheimer’s & Dementia projecting the disease’s likely expansion, and for the firs...

Study evaluates deep learning algorithm in foretelling Alzheimer's

A deep learning algorithm based on F-18 FDG-PET and PET/CT brain scans from the Alzheimer's Disease Neuroimaging Initiative d -More- 

Number of Americans with Alzheimer’s expected to soar in coming decades – CBS News

CBS NewsNumber of Americans with Alzheimer's expected to soar in coming decadesCBS NewsThe number of people living with Alzheimer's disease and related dementias will double by 2060, according to a new study from the Centers for Disease Control and Prevention. Alzheimer's disease is the sixth leading cause of death in the United States ...World Alzheimer's Day 2018: All you need to knowDaily MailC...

Non-drug approaches should be prioritised when treating agitation in Alzheimer’s disease, says expert panel

Non-pharmacological treatment should be favoured over drugs for the management of agitation and aggression in patients with Alzheimer’s disease, according to global experts in the behavioural and psychological symptoms of dementia.

ACM Global Labs Acquires ABS Labs

Expands collection of domestic and international labs focused on bioanalytical, toxicology and central lab testing

Healthy Eating and Alzheimer's Disease

Source: National Institute on Aging - Related MedlinePlus Pages: Alzheimer's Caregivers, Alzheimer's Disease

Global organizations support emerging leaders changing brain health and dementia landscape

(Alzheimer's Association) Three leading organizations in Alzheimer's disease have joined forces to address this growing public health crisis. The Alzheimer's Association, the Global Brain Health Institute (GBHI), and the UK-based Alzheimer's Society have united to support emerging scientists in brain health and dementia through a competitive funding program - The Pilot Awards for Global Brain Heal...

Periodontal disease bacteria may kick-start Alzheimer's

(University of Illinois at Chicago) Long-term exposure to periodontal disease bacteria causes inflammation and degeneration of brain neurons in mice that is similar to the effects of Alzheimer's disease in humans. Periodontal disease may be an initiator of Alzheimer's.

Study: Exercise may delay cognitive decline in people with rare Alzheimer's disease

(Alzheimer's Association) For individuals carrying a genetic mutation that causes Alzheimer's disease, engaging in at least 2.5 hours of physical activity per week may have beneficial effects on markers of Alzheimer's disease brain changes and may delay cognitive decline, according to a new study.

A Common Virus May Play Role in Alzheimer’s Disease, Study Finds

The research did not find that viruses cause Alzheimer’s. But it showed that two types of herpes interact with Alzheimer’s-related genes and might drive the disease process

Exome sequencing in an Italian family with Alzheimer’s disease points to a role for seizure-related gene 6 (SEZ6) rare variant R615H

The typical familial form of Alzheimer’s disease (FAD) accounts for about 5% of total Alzheimer’s disease (AD) cases. Presenilins (PSEN1 and PSEN2) and amyloid-β (A4) precursor protein (APP) genes carry all repor...

Researchers classify Alzheimer’s patients into 6 subgroups

Researchers studying

Biogen Inc.: Data to be Presented From Biogen's Alzheimer's Disease Clinical Development Portfolio at the 2018 Alzheimer's Association International Conference (AAIC)

Ongoing Alzheimer's disease research programs target possible causes of the disease through multiple modalities Data to be presented from Alzheimer's disease clinical development portfolio includi...

Never-before-seen DNA recombination in the brain linked to Alzheimer's disease

Scientists have identified gene recombination in neurons that produces thousands of new gene variants within Alzheimer's disease brains. The study reveals for the first time how the Alzheimer's-linked gene, APP, is recombined by using the same type of enzyme found in HIV. The findings provide rationale for evaluating HIV antiretroviral therapies in people with Alzheimer's. It also provides an expl...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks